Angiotensin-converting enzyme 2-based mutant decoy effective

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

Related Keywords

Aimee Molineux , Neha Mathurmar , Neha Mathur , Kateryna Kon Shutterstock , Trends In Pharmacological Sciences , Pharmacological Sciences , Angiotensin , Ngiotensin Converting Enzyme 2 , Coronavirus Disease Covid 19 , Covid 19 , Nzyme , Ce2 , Antibodies , Binding Affinity , Fell , Coronavirus , Bedema , N Vitro , Lungs , Micron , Pandemic , Protein , Espiratory , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome , Ransgenic , Virus ,